FitLife Brands, Inc. (FTLF)
NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-07-23
Reading FTLF? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-07-23
Reading FTLF? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
FTLF represents a durable compounder in the Consumer Staples sector. The current thesis state is intact, supported by recent earnings beats and a stable management team, but it faces high risk factors.
The market seems to have priced in a low level of execution quality, indicating a stretched valuation compared to peers. There is an expectations gap, suggesting that some positive developments may not be fully recognized yet.
Management is focused on achieving adjusted EBITDA of $20-25 million and exceeding $120 million in consolidated revenue for the first full year. Recent financial trends show progress toward these targets, although there is a low probability of missing expectations.
The long-term thesis hinges on management's ability to maintain guidance and deliver on financial targets. Additionally, sector momentum from larger Consumer Staples companies and inflation trends could significantly impact FTLF's performance.
Over the next 1 to 3 years, FTLF's outlook depends on management execution and external market conditions. Not investment advice.
The most important moves since the prior daily snapshot.
No, our read on the company is unchanged. The financial performance remains strong, holding in the top half of its industry, which supports the thesis that the reason to own it still holds. There are no new threats or supports that would alter the current assessment.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Achieving adjusted EBITDA of $20-25 million is key for growth. It shows financial health.
Confirms:Q2 adjusted EBITDA was between $20 million and $25 million.
Disproves:Q2 adjusted EBITDA was less than $20 million.
Why it matters: Stable or growing Legacy FitLife revenue is key for the company's health. This comes after recent declines.
Confirms:Legacy FitLife revenue stays the same or grows compared to Q1 2026.
Disproves:Legacy FitLife revenue continues to decline in Q2 2026.
Why it matters: GDP growth affects consumer spending. Strong GDP can signal better sales for FitLife.
Confirms:GDP growth revised up to above 2% for Q1 2026.
Disproves:GDP growth revised down to below 1% for Q1 2026.
Why it matters: Exceeding $120 million in annual revenue shows strong growth. It builds investor confidence.
Confirms:Q2 revenue was above $30 million.
Disproves:Q2 revenue was below $30 million.
Why it matters: The FOMC decides on interest rates. This affects how much people spend and invest. Changes can impact FitLife's sales.
Confirms one read:FOMC raises rates by 25 basis points or more.
Confirms the other:FOMC keeps rates unchanged or lowers them.
Why it matters: This report shows retail sales trends. Strong sales could boost FitLife's outlook.
Confirms:Retail sales growth above 0.5% month over month.
Disproves:Retail sales growth below 0% month over month.
Why it matters: Strong growth on Amazon shows more demand for Irwin products. This helps with supply chain issues.
Confirms:Irwin's Amazon revenue hits or goes over $1 million in April 2026.
Disproves:Irwin's Amazon revenue does not reach $1 million in April 2026.
Why it matters: Reaching this target shows strong operations and good cost management.
Confirms:Management says adjusted EBITDA is at or above $20 million for the full year 2026.
Disproves:Adjusted EBITDA falls below $20 million for the full year 2026.
Why it matters: Going beyond this target shows strong growth and good integration of Irwin.
Confirms:Total revenue reported above $120 million for the full year 2026.
Disproves:Total revenue falls below $120 million for the full year 2026.